Diplomat Pharmacy, Inc. (DPLO): Price and Financial Metrics


Diplomat Pharmacy, Inc. (DPLO)

Today's Latest Price: $4.00 USD

0.01 (0.25%)

Updated Feb 7 6:40pm

Add DPLO to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

See all "A" rated Strong Buy stocks

DPLO Stock Summary

  • NA's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.4% of US listed stocks.
  • DPLO's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.02 -- higher than merely 0.64% of US-listed equities with positive expected earnings growth.
  • In terms of twelve month growth in earnings before interest and taxes, NA is reporting a growth rate of -2,110.81%; that's higher than merely 0.74% of US stocks.
  • Stocks that are quantitatively similar to DPLO, based on their financial statements, market capitalization, and price volatility, are NCSM, CIR, AFH, SMIT, and TSRI.
DPLO Daily Price Range
DPLO 52-Week Price Range

DPLO Stock Price Chart More Charts


DPLO Price/Volume Stats

Current price $4.00 52-week high $14.46
Prev. close $3.99 52-week low $2.43
Day low $4.00 Volume 744,900
Day high $4.01 Avg. volume 795,738
50-day MA $4.18 Dividend yield N/A
200-day MA $5.01 Market Cap 304.00M

Diplomat Pharmacy, Inc. (DPLO) Company Bio


Diplomat Pharmacy operates as an independent specialty pharmacy in the United States. The company stocks, dispenses, and distributes prescriptions for various biotechnology and specialty pharmaceutical manufacturers. The company was founded in 1975 and is focused in Flint, Michigan.


DPLO Latest News Stream


Event/Time News Detail
Loading, please wait...

DPLO Latest Social Stream


Loading social stream, please wait...

View Full DPLO Social Stream

DPLO Price Returns

1-mo 0.00%
3-mo -18.37%
6-mo -31.15%
1-year -33.33%
3-year -72.05%
5-year -86.67%
YTD 0.00%
2019 -70.28%
2018 -32.93%
2017 59.29%
2016 -63.18%
2015 25.03%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6902 seconds.